Stromectol tablets 3 mg for parasites (strongyloidiasis, scabies, ivermectin)

General information on Japanese Stromectol tablets 3 mg for parasites (strongyloidiasis, scabies, ivermectin)

Package details: 10 tablets

Manufacturer: Maruho Co., Ltd., Japan

Active ingredient: ivermectin (chemical formula C47H72O14)

Medical effect: Stromectol tablets are effective for the treatment of parasites.

Contraindications and precautions: do not use for pregnant or breastfeeding women. Do not use for immunocompromised patients (including HIV-infected, HLTV-1-infected, etc.) or patients co-infected with Onchocerciasis or Loa loa.

If an allergic reaction occurs, stop taking the medicine and consult with your doctor. If you’re taking any other medication, please consult with your doctor before use.

This medicine may cause transient exacerbation of pruritus during initial therapy.

Dosage and administration of Stromectol tablets 3 mg from Japan for parasites (strongyloidiasis, scabies, ivermectin)

For intestinal strongyloidiasis: for adults, take approximately 200 mcg of the active ingredient per 1 kg of weight at a time. Take the medicine on an empty stomach with water, twice at a 2-week interval.

For scabies: for adults, take approximately 200 mcg of the active ingredient per 1 kg of weight at a time. Take the medicine on an empty stomach with water, once.

How effective are Stromectol tablets 3 mg from Japan for parasites (strongyloidiasis, scabies, ivermectin)?

Stromectol tablets contain ivermectin, an approximately 80:20 mixture of two avermectin B1 derivatives, called 22,23-dihydroavermectin B1a and B1b. It works by interfering with nerve and muscle function of helminths and insects. As the result, Stromectol tablets cause paralysis, death and extermination of the parasites.

Who should take Stromectol tablets 3 mg from Japan?

Stromectol tablets are approved in Japan for the treatment of intestinal strongyloidiasis and scabies. However, multiple studies also showed that ivermectin is effective for the treatment of:

• head lice,
• river blindness (onchocerciasis),
• trichuriasis,
• ascariasis,
• lymphatic filariasis.

Furthermore, this medicine is relatively safe as it does not show any genotoxic activity and does not penetrate through the hematoencephalic barrier in mammals (A. L. Dourmishev, L. A. Dourmishev, R. A. Schwartz "Ivermectin: pharmacology and application in dermatology". International Journal of Dermatology. 2005, December, 44 (12): 981–8).